Effects of protein kinase inhibitors 1(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) and N-[2-guanidinoethyl]-5-isoquinolinesulfonamide hydrochloride (HA1004) on calcitriol-induced differentiation of HL-60 cells by Martell, Robert E. et al.
Biochemical Pharmacology, Vol. 37. No. 4, pp. 635-640, 1988. CM&-295y88 $3.00 + 0.00 
Printed in Great Britain. 0 1988. Pergamon Journals Ltd. 
EFFECTS OF PROTEIN KINASE INHIBITORS 
1(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE 
DIHYDROCHLORIDE (H-7) AND N-[2-GUANIDINOETHYLI- 
5-ISOQUINOLINESULFONAMIDE HYDROCHLORIDE 
(HA1004) ON CALCITRIOL-INDUCED DIFFERENTIATION 
OF HL-60 CELLS* 
ROBERT E. MARTELL, ROBERT U. SImsoNt and TODD Hsu 
Department of Pharmacology and The Center for Molecular Genetics, University of Michigan, 
School of Medicine, Ann Arbor, MI 48109, U.S.A. 
(Received 8 May 1987; accepted 8 July 1987) 
Abstract-HL-60 promyelocytic leukemia cells were induced to differentiate by 1,25_dihydroxyvitamin 
D3 (calcitriol) into mature monocytes. Differentiation was assessed by nitro blue tetrazoliuin dye 
reduction, nonspecific esterase activity, and DNA synthesis. Terminal differentiation of cultures induced 
by calcitriol (1bnM) was inhibited- by 80% whkn cells were treated simultaneously with protein 
kinase inhibitors l-(5-isoauinolinesulfonv%2-methvlninerazine dihvdrochloride (H-71 (32 uMI and N-12- 
guanidinoethyll-5-isoquionlinesulfonamid hydroihiohde (HA1064) (320 PM).‘ The ;c,’ for'inhibitibn 
of calcitriol-induced differentiation was approximately 15 PM for H-7 and 170 PM for HA1004. The lcsO 
values for H-7 and HA1004 antagonism of calcitriol-induced differentiation are quantitatively and 
relatively correlated to their known action to inhibit protein kinase C activity. Treatment of cells with 
concentrations of O-32 PM H-7 or &32OpM HA1004 alone did not affect cell growth, differentiation, 
or trypan blue exclusion. However, higher concentrations of H7 (> 32 PM) and HA1004 (> 320 PM) were 
found to be cytotoxic. The data presented suggest that calcitriol-induced differentiation is antagonized by 
inhibitors of protein kinase and are consistent with the hypothesis that kinase C activity is required for 
HL-60 cell differentiation. 
Human HL-60 promyelocytic leukemia cells con- 
stitute a useful cell culture system for the study of 
cellular differentiation. HL-60 cells can be induced 
to terminally differentiate to morphologically mature 
myeloid cells by a wide variety of compounds includ- 
ing DMSO$, RA, phorbol diesters and calcitriol [l- 
91. DMSO and RA induce mature neutrophil-like 
cells, whereas calcitriol and phorbol diesters induce 
differentiation to a monocyte-macrophage pheno- 
type [l-9]. 
In this report we studied the relationship between 
differentiation induced by phorbol diesters and cal- 
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citriol. Biologically active phorbol diesters have been 
shown to interact with a calcium and phospholipid- 
dependent protein kinase [N-14]. There is much 
evidence indicating that the receptor for phorbol 
diesters is protein kinase C (PKC) [10-141. We 
recently demonstrated that phorbol diester receptor 
levels increase early in the course of calcitriol- 
induced differentiation [El. Lane et al. [16] have 
shown that DMSO-induced differentiatiofi is also 
accompanied by increased levels of phorbol diester 
receptor. These observations suggest that the phor- 
bol diester receptor, PKC, is involved in calcitriol- 
induced differentiation. 
Inhibitors of protein kinase activity have been 
synthesized and characterized [17]. Isoquinoline- 
sulfonamides (IQSA) interact directly with the cata- 
lytic site of the protein kinase and most likely induce 
their response by competing with ATP binding to 
kinases. Hidaka et al. [17] have characterized the 
relative potency of IQSA kinase inhibitors and have 
shown that 1-(5-isoquinolinesulfonyl)-2-methyl- 
piperazine dihydrochloride (H-7) is more potent 
(lo-fold) an inhibitor of PKC than N-(2-guan- 
idinoethyl)-S-isoquinolinesulfonamide hydro- 
chloride (HA1004). In contrast, these studies showed 
that HA1004 was a more potent inhibitor of cGMP- 
and CAMP-dependent protein kinases than PKC 
[17]. These IQSA inhibitors are readily incorporated 
into intact cells [17]. Furthermore, H-7 has been 
used by others to study protein kinase C dependent 
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processes in isolated intact platelets and in aortic and 
atria1 muscle preparations [18-191. In the present 
study, we examined the effects of inhibitors of pro- 
tein kinases (H-7 and HA1004) on calcitriol-induced 
HL-60 cell differentiation. 
MATERIALS AND METHODS 
[~~]Thymidine was purchased from New England 
Nuclear (Boston, MA). Dulbecco’s phosphate-buf- 
fered saline (PBS), bovine gamma globulin, horse 
serum, HEPES buffer, citrate buffer, Trizma 7.6 
buffer, fast blue RR salt, alpha napthyl acetate, 
Mayer’s hematoxylin Triton X-100 solution and TPA 
were all purchased from Sigma (St. Louis, MO). 
H-7 and HA1004 were purchased from Seikagaku 
America Inc. (St. Petersburg, FL). Calcitriol was 
purchased from the Du Phor Co. (Amsterdam, 
Netherlands). Vitamin D metabolite purity and 
structural integrity were confirmed by UV spectro- 
scopy. HL-60 promyelocytic leukemia cells were 
obtained from Dr. Beverly Mitchell of The Uni- 
versity of Michigan and cultured in RPM1 1640 
medium from Irvine Scientific (Irvine, CA) with 10% 
horse serum in a humidified atmosphere of 95% air 
and 5% COZ at 37”. 
Difierentiution of HL-60 cells. HI.,-60 cells in log 
phase growth at an initial cell count of approximately 
2 X 10 cells/ml were treated with ethanol or 10 nM 
calcitriol and various concentrations of H-7 or 
HA1004 (vehicle 50% ETOH) for periods as noted 
for each experiment. Cell differentiation was 
assessed by NBT dye reduction, nonspecific esterase 
activity, and DNA synthesis. 
NBT dye reduction. Assessment of cell dif- 
ferentiation in control and treated cells was measured 
by NBT reduction as previousiy described [18]. Cells 
at a density of 1 X l~cells/ml in growth medium 
containing 10% horse serum were incubated for 
80 min at 37” in an atmosphere of 5% COZ and air 
with an equal volume of NBT (2mg/ml) solution 
which contained TPA at a final concentration of 
500nM. The percentage of cells containing intra- 
cellular blue-black formazan deposits was deter- 
mined by microscope examination immediately after 
NBT incubation. Relative cell concentrations were 
obtained as well since cell solution counting was done 
with a hemacytometer. Triplicate determinations of 
at least 100 cells were performed for each treated 
culture. 
Nons~e~l~c esteruse uct~vi~. Nonspecific esterase 
activity was determined cytochemically using a com- 
mercially available kit (Sigma Chemical Co). After 
centrifugation and aspiration of the medium, cells 
were spread on a glass microscope slide, air dried, 
and fixed with a citrate-acetone-methanol fixative. 
The stain was prepared by mixing 200 @g/ml Fast 
Blue RR salt in Trizmal, pH 7.6, buffer and a second 
solution containing 10 mg/ml of alpha naphthyl acet- 
ate in ethylene glycol monomethyl ether. These solu- 
tions were combined at 37” in a 25: 1 ratio, 
respectively, and added to staining jars. Slides were 
incubated for 30 min at 37” in staining solution. Slides 
were then counterstained in Mayer’s hematoxylin 
solution for 5 min. The percentage of cells containing 
dark blue deposits was quantitated visually by micro- 
scope. A minimum of three slides with 100 cells each 
was counted. 
Measurement of DNA synthesis. HL-60 cells were 
assayed for DNA synthetic capacity as previously 
described [15]. At indicated time points and various 
treatment regimens, cells were incubated in the pres- 
ence of 1 PCi of 13H]thymidine (sp. act. 20 Ci/mmol) 
per ml of growth medium for 1 hr. Cells were col- 
lected and rinsed twice in phosphate-buffered saline, 
lysed with 600 ,ul of 1 N NaOH at 37” for 30 min, and 
neutralized with 1 N HCl. Total protein was assayed 
by the method of Bradford f203 Acid-insoluble 
material was precipitated by addition of 2 ml of ice- 
cold 10% TCA. TCA prepipitates were collected on 
2.4cm Whatman GF/C glass fiber filters, washed 
twice with ice-cold 10% TCA and once with ice-cold 
ethanol. Filters were dried and counted using liquid 
scintillation spectroscopy. 
RESULTS 
Inhibition of diflerentiation by markers H-7 and 
HA1004. The effects of protein kinase inhibitors H- 
7 and HA1004 on calcitriol-induced differentiation 
are shown in Figs. 1 and 2. Figure 1 shows the effects 
of H-7 and HA1004 on calcitriol-induced NBT 
reduction capacity in HL-60 cells. Each point is 
represented as a percentage of markers expressed in 
cultures that were treated with calcitriol(l0 nM) and 
no kinase inhibitor. Standard error was determined 
by examining three microscope fields of at least 100 
cells for each data point. The ICY,, for inhibition of 
differentiation was approximately 11 ,uM for H-7 and 
2OOpM for HA1004 for this experiment (Fig. 1). 
Similar results were obtained in three other separate 
experiments. Differentiation was further assessed 
using another marker for differentiation, nonspecific 
esterase activity. Figure 2 shows the concentration- 
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Fig. 1. Concentration-dependent effects of H-7 and 
HA1004 on a calcitriol (10nM) induced HL-60 dif- 
ferentiation marker, NBT dve reduction. Cultures of cells 
treated with calcitriol for 48 hr and microscopically assayed 
for cell NBT dye reduction capacity were found to exhibit 
this differentiation marker in 58 +- 3% (N = 3 2 SE) of 
cells. We assayed cellular NBT dye reduction capacity in 
cultures simultaneously treated with calcitriol (10 nM) and 
various concentrations of H-7 (a) and HA1004 (B). Data 
are expressed as percent of control cells exhibiting NBT 
reduction by 10 nM calcitriol (100%) in the absence of H- 
7 or HA&I. Each point is the mean of three deter- 
minations (’ SE). Four identical experiments yielded 
quantitatively similar results. 
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Fig. 2. Concentration-dependent effects of H-7 and 
HA1004 on calcitriol (10 nM) induced nonspecific esterase 
activity, a marker differentiation, in HL-60 cells. Cultures 
treated with calcitriol for 48 hr were assayed micro- 
scopically for cell nonspecific esterase activity and were 
found to exhibit this marker in 60 t 4% of cells after 48 hr. 
We assayed for cellular nonspecific esterase activity in 
cultures simultaneously treated with calcitriol (10 nM) and 
various concentrations of H-7 (0) and HA1004 (B). Data 
are expressed as percent of control cells exhibiting esterase 
activity after 10 nM calcitriol treatment (100%) in the 
absence of H-7 or HA1004. Each point is the mean of three 
determinations (f SE). Four identical experiments yielded 
quantitatively similar results. 
dependent capacities of H-7 and HA1004 to inhibit 
calcitriol-induced differentiation as measured by 
total nonspecific esterase activity (NEA). For this 
marker it was calculated that the lcso for inhibition 
of calcitriol-induced differentiation by. H-7 was 
20 PM and by HA1004 was 165 PM. Standard error 
was determined as for the NBT assay. A similar curve 
for inhibition of those markers of differentiation 
with H-7 (1~~~ = 9.0) was also obtained using 100 nM 
calcitriol to differentiate cells (data not shown). The 
ICKY values reported in the abstract were derived by 
averaging three experiments measuring the effects 
of H-7 and HA1004 on NBT and nonspecific esterase 
activity. 
Photomicrograph of HL-60 cells. Control cells 
without kinase inhibitor treated with 10 nM calcitriol 
or ethanol for 48 hr and assayed for NBT dye 
reduction capacity are shown in Fig. 3A and B. 
Calcitriol-treated cells that were incubated with 
18 ,uM H-7 are shown in Fig. 3C. A lower percentage 
of cells were differentiated (dark granulated cells) in 
calcitriol-treated cells in the presence of H-7 than in 
cells treated with calcitriol(l0 nM) alone. Panels A- 
C of Fig. 4 are photomicrographs of HL-60 cells 
stained for nonspecific esterase activity for control 
cells, calcitriol (10 nM) dosed cells and calcitriol 
dosed cells in the presence of 18 PM H-7 respectively. 
Effects of kinase inhibitors on calcitriol-induced 
inhibition of DNA synthesis. HL-60 cells at 2 x 105/ 
rn! pere treated with 10 nM calcitriol for 72 hr. This 
time was chosen for assessing DNA synthesis because 
previous experiments showed that calcitriol did not 
consistently inhibit DNA synthesis until approxi- 
mately 72 hr. A decrease in DNA synthesis of 
approximately 50% was observed (Fig. 5). As shown, 
H-7 (18 PM) was able to reverse the decrease in 
DNA synthesis. HA1004 also at a concentration of 
18 ,uM had no effect on calcitriol-induced inhibition 
NBT 
CALCITRIOL CALCITRIOL (10 nM) 
(10 ntd) H7 (18 uM) 
CONTROL 
A B C 
Fig. 3. Photomicrographs of HL-60 cells (300x) assayed for NBT dye reduction. Cells were treated for 
48 hr with calcitriol (10 nM) and H-7 (18 PM). The cells were then incubated in the presence of 2 mg/ 
ml NBT and 5OOpM TPA for 80min. and photographed. Key: (A) control cells in the absence of 
calcitriol and H-7; (B and C) calcitriol-treated cells without and with H-7 respectively. 
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NONSPECIFIC ESTERASE 
CONTROL CALCITRIOL ~ALCI~RIOL (15 nM) 
(10 nM) H7 (18 uM) 
C 
Fig. 4. Photomicrographs (300x) of HL-60 cells assayed for nonspecific esterase activity. Cells were 
treated for 48 hr with calcitriol(10 nM) and H-7 (18 PM). Cells were then dried and fixed to a microscope 
slide followed by a 30min incubation in the presence of 10 mg/ml alpha naphthyl acetate and 200 +ug/ 
ml Fast Blue RR salt. Counter staining was done with Mayer’s hematoxylin solution. Key: (A) 
photomicrograph of control cells in the absence of calcitriol and H-7; (B and C) calcitriol-treated cells 
without and with H-7 respectively. 
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Fig. 5. Effect of calcitriol on DNA synthesis in the absence 
and presence of H-7 and HA1004 kinase inhibitors. HL-60 
cells grown in 10% horse serum were treated with the 
indicated concentrations of calcitriol. H-7 and HA1004 for 
72 hr. Following treatment, cells were assayed for 13H]dThd 
incorporation as described in Materials and Methods, 
Results are expressed as percentage of control cells assayed 
in the absence of calcitriol and kinase inhibitors. Control 
incorporation was 6587 cpm/l@ cells. Each bar represents 
the mean t SE of four replicates. Meanvalues for [3H]dThd 
incorporation in calcitriol-treated cultures and for calcitriol 
and HA1004 (18~M) treated cultures were significantly 
different from nontreated control cultures as determined by 
Student’s r-test (P < 0.01). However, mean values reported 
for calcitriol-treated cells in the presence of H-7 (18 GM) 
and HA1004 (180 PM) were not significantly different from 
control (P > 0.05) cultures. 
of DNA synthesis (Fig. 5). A concentration of 
180 PM HA1004 was required to block the effect of 
calcitriol on HL-60 DNA synthesis. 
Cell viability. At concentrations greater than 
32 PM H-7 or 32OpM HAlOO4, cells were unable 
to exclude trypan blue and were morphologiea~ly 
altered to rough, asymmetric cells. At 32gM H-7 
and 320 PM HA1004, cells excluded trypan blue and 
were not differentiated as assessed by NBT dye 
reduction and NEA (data not shown). However, 
these concentrations of H-7 and HA1004 yielded 
morphologically asymmetric cells with many vacu- 
oles. Treatment of cells with concentrations of H-7 
from 0 to 18pM or HA1004 from 0 to 100,~M had 
no effect on cell growth, morphology, trypan blue 
exclusion, and differentiation as determined by our 
assays. The magnitude of the activity of H7 and 
HA1004, as shown in Figs. 1 and 2, was limited by 
inhibitor toxicity at higher concentrations. 
DISCUSSION 
HL-60 promyelocytic leukemia have proven to 
be useful for studying cellular differentiation. The 
mechanisms involved in cell differentiation have 
been examined extensively in this cell line, and cor- 
relations of various cellular events with differ- 
entiation have yielded insight into the mechanism 
of cell differentiation [l-9]. HL-60 differentiation 
occurs in conjunction with, or is preceded by, regu- 
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lation of oncogene and enzyme activities, including 
kinases 121-281. Our laboratory is interested in the 
action of calcitriol to differentiate HL-60 cells. In 
this study, differentiation was assessed by measuring 
cell NBT dye reduction, nonspecific esterase activity, 
and cell DNA synthesis. We showed that calcitriol 
modulates these activities as early as 24 hr after 
induction 121,261. 
Protein phosphorylation plays a significant role in 
modulating many cellular processes. Kuo, 
Nishizuka, and collaborators have demonstrated that 
PKC is an important regulatory enzyme and it is now 
accepted that the mechanism by which PKC regulates 
cellular processes, including control of signal 
transduction, cell division and differentiation, 
involves specific protein phosphorylation [29,30]. 
The importance of protein kinase C activity for 
induction of differentiation in HL-60 cells has been 
examined. Helfman et al. [31] showed that Ca2+- 
phospholipid dependent protein kinase C is preva- 
lent in leukemia cell lines including the HL-60 line. 
Fontana et al. [27,28] demonstrated an elevation in 
Caa+-phospholipid dependent protein kinase activity 
after induction of HL-60 cells with retinoic acid. 
Kraft and Anderson [32] have also shown this to 
occur in F9 tetracarcinoma cells. 
We previously showed that binding of ~3H]phorbol 
dibutyrate to HL-60 cells increases early in the pro- 
cess of differentiation [15]. This report is our initial 
attempt to characterize further the importance of 
PKC activity for HL-60 cell differentiation by 
making use of the protein kinase inhibitors H-7 and 
HA1004 which interact directly with the enzyme. 
Hidaka and others have shown that H-7 produces a 
selective inhibition of protein kinase C in platelets, 
smooth muscle and cardiac muscle without inhibiting 
other kinases such as myosin light chain kinase [17- 
191, whereas HA1004 is more selective for CAMP, 
cGMP and myosin light chain kinases. We report 
here that these inhibitors blocked calcitriol-induced 
di~erentiation of HL-60 cells in a dose-dependent 
manner. Importantly, H-7 was approximately ten 
times as potent as HA1004 in this regard. Maximal 
inhibition of differentiation markers was 80%. We 
show that the total number of cells exhibiting these 
markers was decreased by treatment with these pro- 
tein kinase inhibitors (Figs. 1-3). The population 
of cells that we assume are undifferentiated in all 
treatment conditions appeared similar to control cells 
as assayed by NBT reduction and nonspecific ester- 
ase activity. Moreover, we have demonstrated that 
subtoxic doses of protein kinase inhibitors alone did 
not affect DNA synthesis, cell growth, trypan blue 
exclusion or cell differentiation markers. 
Cell toxicity of kinase inhibitors (H7 and Halos) 
was evident at concentrations greater than 32 PM for 
H-7 and greater than 320pM for HA1004. Inter- 
estingly, cell toxicity corresponded to approximately 
five times the reported Ki values for inhibition of 
protein kinase C activity, and toxicity does not cor- 
relate with the relative Ki values reported for cGMP- 
dependent, CAMP-dependent or myosin light chain 
(MLC) kinases [17]. Furthermore, the ICKY values 
obtained from our data of inhibition of differ- 
entiation correlated with those values reported for 
inhibition of PKC phosphorylation in uitro [17]. 
Although our data are consistent with the hypoth- 
esis that protein kinase C activity is essential for 
calcitriol induction of differentiation of HL-60 cells, 
it is correlative. Recently, however, evidence has 
accumulated to further support this hypothesis. First, 
calcitriol and phorbol esters (a potent stimulant of 
kinase C activity) both induce differentiation of HL- 
60 cells along the monocytic pathway [S, 7-9,211. 
Second, Zylber-Katz and Glazer [ll] have shown 
that calcitriol induces an increase in calcium and 
phospholipid kinase activity concurrent with cell dif- 
ferentiation. Third, calcitriol has been shown to 
induce an increase in phorbol ester receptors early 
in the course of differentiation [lSJ. Fourth, the 
time course for phorbol ester induced differentiation 
precedes calcitriol induction [5,7-9,211. Fifth, we 
show that H-7, a selective inhibitor of PKC activity, 
blocked calcitriol induction of differentiation. Sixth, 
HA1004, a kinase inhibitor with a greater relative 
potency for inhibiting CAMP-dependent cGMP- 
dependent and myosin light chain kinases, was less 
potent at blocking HL-60 cell differentiation than H- 
7. However, it is of interest that the increases in PKC 
phosphorylation activity and phorbol ester binding 
capacity are also induced by agents (e.g. DMSO) 
that differentiate HL-60 cells along the granulocytic 
pathway 116,221. This suggests that the induction of 
PKC activity is not sufficient to determine the end 
product of HL-60 cell differentiation. It further sug- 
gests that the determinant for pathway selection, 
monocyte or granulocyte, may be dictated by acti- 
vation of distinct PKC isozymes or by factors other 
than PKC. In summary, data presented here suggest 
that the action of calcitriol to induce HL-60 cell 
differentiation requires protein kinase activity and 
correlates with the concept that protein kinase C is 
the responsible kinase. 
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